ConductScience.org, home

Paper39765340

Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study.

Buford K and 7 others. Int Neurourol J, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study. Papers, record 39765340. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39765340

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study.
PubMed
Journal
Int Neurourol J
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.88, provisional
iCite
Revised in PubMed
2025-01-11
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Buford KKaris
2Eisner HHaley
3Vollstedt AAnnah
4Friedman BBrett
5Gilleran JJason
6Zwaans BMMBernadette M M
7Peters KMKenneth M
8Padmanabhan PPriya

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133556449The Effect of Sacral Neuromodulation in Ambulatory Spina Bifida Patients with Neurogenic Bladder and Bowel Dysfunction.Urology2021https://conductscience.org/library/papers/33556449PubMed
238417466Feasibility of Sacral Neuromodulation in Patients With Underlying Neurologic Lower Urinary Tract Dysfunction and Fecal Incontinence.Urology2024https://conductscience.org/library/papers/38417466PubMed
324394604Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience.Spinal Cord2014https://conductscience.org/library/papers/24394604PubMed
421488095Sacral neuromodulation for treating neurogenic bladder dysfunction: clinical and urodynamic study.Neurourol Urodyn2011https://conductscience.org/library/papers/21488095PubMed
525224602Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease.Spinal Cord2015https://conductscience.org/library/papers/25224602PubMed
611744452Chronic sacral neuromodulation for treatment of neurogenic bladder dysfunction: long-term results with unilateral implants.Urology2001https://conductscience.org/library/papers/11744452PubMed
733713279Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years' Experience and Future Directions.Adv Ther2021https://conductscience.org/library/papers/33713279PubMed
826215913Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction.Spinal Cord2016https://conductscience.org/library/papers/26215913PubMed
938319849Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction.NEJM Evid2022https://conductscience.org/library/papers/38319849PubMed
1035216773Percutaneous posterior tibial nerve stimulation (PTNS) for lower urinary tract symptoms (LUTSs) treatment in patients with multiple sclerosis (MS): A systematic review and meta-analysis.Mult Scler Relat Disord2022https://conductscience.org/library/papers/35216773PubMed
1130138720A Review of Botulinum Toxin A for the Treatment of Neurogenic Bladder.PM R2019https://conductscience.org/library/papers/30138720PubMed
1223537757Clinical outcomes of sacral neuromodulation in patients with neurologic conditions.Urology2013https://conductscience.org/library/papers/23537757PubMed
1335579275Neuromodulation for lower urinary tract symptoms in special populations.Neurourol Urodyn2022https://conductscience.org/library/papers/35579275PubMed
1422151195Findings with Bilateral Sacral Neurostimulation: Sixty-two PNE-Tests in Patients with Neurogenic and Idiopathic Bladder Dysfunctions.Neuromodulation2004https://conductscience.org/library/papers/22151195PubMed
1521400258Sacral neuromodulation in patients with multiple sclerosis.World J Urol2012https://conductscience.org/library/papers/21400258PubMed
1619876582Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization.Int Urogynecol J2010https://conductscience.org/library/papers/19876582PubMed
1729149505An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD).Neurourol Urodyn2018https://conductscience.org/library/papers/29149505PubMed
1826904417Neuromodulation in neurogenic bladder.Transl Androl Urol2016https://conductscience.org/library/papers/26904417PubMed
1920955907Neuromodulation and the neurogenic bladder.Urol Clin North Am2010https://conductscience.org/library/papers/20955907PubMed
2026498275Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.BMC Urol2015https://conductscience.org/library/papers/26498275PubMed

See all 26 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42483687Induced diabetic neurogenic bladder animal models: application characteristics and standardization proposals via systematic data mining.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42483687PubMed
42311737Sacral Neuromodulation Outcomes for Managing Urinary Incontinence in Patients With Overactive and Neurogenic Bladder.Cureus2026https://conductscience.org/library/papers/42311737PubMed
41986359Wireless electrostimulation implants enable sphincter neuromuscular improvement toward mixed urinary incontinence.Nat Commun2026https://conductscience.org/library/papers/41986359PubMed
40549020Off-Label but On-Target: Sacral Neuromodulation for Neurogenic Bladder Dysfunction.Curr Urol Rep2025https://conductscience.org/library/papers/40549020PubMed
39765336Innovation and the Importance of Patient-Centered Treatment.Int Neurourol J2024https://conductscience.org/library/papers/39765336PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39765340

GET https://conductscience.org/api/papers/v1/39765340/references?page=2